Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -593 | 8,177 | 4,945 | 4,368 | 5,014 |
| Depreciation Amortization | 87 | 638 | 456 | 302 | 151 |
| Accounts receivable | 0 | 24 | 24 | -1 | -1 |
| Accounts payable and accrued liabilities | 78 | 55 | 40 | -6 | 64 |
| Other Working Capital | 256 | 1,164 | 278 | 144 | 76 |
| Other Operating Activity | 79 | -10,820 | -6,452 | -5,349 | -5,562 |
| Operating Cash Flow | $-93 | $-762 | $-708 | $-543 | $-258 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -58 | -58 | -58 | -58 |
| Other Investing Activity | 10 | 85 | 34 | -15 | -4 |
| Investing Cash Flow | $10 | $27 | $-24 | $-73 | $-62 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 203 | 863 | 772 | 515 | 162 |
| Debt Repayment | -120 | -684 | -382 | -232 | -120 |
| Other Financing Activity | 0 | 465 | 251 | 251 | 194 |
| Financing Cash Flow | $83 | $644 | $642 | $535 | $236 |
| Beginning Cash Position | N/A | 91 | 91 | 91 | 91 |
| End Cash Position | N/A | N/A | N/A | 10 | 7 |
| Net Cash Flow | $0 | $-91 | $-91 | $-81 | $-84 |
| Free Cash Flow | |||||
| Operating Cash Flow | -93 | -762 | -708 | -543 | -258 |
| Capital Expenditure | N/A | -58 | -58 | -58 | -58 |
| Free Cash Flow | -93 | -820 | -766 | -601 | -316 |